Valuation : AbbVie Inc.

Market Cap 451B 389B 365B 333B 626B 42,956B 630B 4,325B 1,683B 21,783B 1,695B 1,658B 72,124B P/E 2026 *
32.6x
P/E 2027 * 24.1x
Enterprise Value 512B 441B 414B 378B 710B 48,712B 715B 4,904B 1,908B 24,701B 1,922B 1,880B 81,788B EV / Sales 2026 *
7.57x
EV / Sales 2027 * 6.84x
Free-Float
95.71%
Yield 2026 *
2.68%
Yield 2027 * 2.82%
1 day+0.22%
1 week-3.12%
Current month+2.12%
1 month+2.12%
3 months+20.35%
6 months+9.58%
Current year+12.16%
1 week 252.33
Extreme 252.33
266.9
1 month 241.2
Extreme 241.2
266.96
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Date Insider Type Main position Quantity % Market Cap. Importance
14/08/26 Exercice

Executive/Senior Manager

98,130 0.0056%
30/06/26 Free

Director

62 0.0000%
30/06/26 Free

Director

134 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%-3.12%+20.93%+74.38% 451B
-1.37%-7.25%+57.31%+108.69% 1,047B
-0.52%-2.42%+49.63%+64.79% 646B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.31%-2.95%+50.12%+68.03% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.44%-0.20%+29.93%+91.47% 181B
+1.52%+1.45%+13.59%-19.80% 159B
Average -0.55%-2.45%+26.01%+41.85% 381.86B
Weighted average by Cap. -0.81%-3.33%+35.61%+61.30%

Financials

2026 *2027 *
Net sales 67.58B 58.19B 54.64B 49.88B 93.7B 6,431B 94.37B 647B 252B 3,261B 254B 248B 10,797B 73.52B 63.3B 59.44B 54.26B 102B 6,995B 103B 704B 274B 3,547B 276B 270B 11,745B
Net income 13.86B 11.93B 11.21B 10.23B 19.22B 1,319B 19.36B 133B 51.67B 669B 52.05B 50.92B 2,214B 18.91B 16.28B 15.29B 13.96B 26.22B 1,800B 26.41B 181B 70.5B 913B 71.02B 69.47B 3,022B
Net Debt 60.49B 52.08B 48.9B 44.64B 83.86B 5,756B 84.46B 579B 225B 2,919B 227B 222B 9,664B 51.66B 44.48B 41.77B 38.12B 71.62B 4,916B 72.13B 495B 193B 2,493B 194B 190B 8,253B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
31/08/26 $256.22 +0.29% 1,012,800
28/08/26 $255.48 -1.03% 3,224,862
27/08/26 $258.15 -1.81% 4,764,797
26/08/26 $262.90 -1.09% 3,308,871
25/08/26 $265.79 +0.48% 3,671,623
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
255.48USD
Average target price
276.59USD
Spread / Average Target
+8.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock